Premium
Mitochondrial toxicity in hearts of CD‐1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination
Author(s) -
Chan Sherine S.L.,
Santos Janine H.,
Meyer Joel N.,
Mandavilli Bhaskar S.,
Cook Dennis L.,
McCash Consuelo L.,
Kissling Grace E.,
Nyska Abraham,
Foley Julie F.,
van Houten Bennett,
Copeland William C.,
Walker Ver E.,
Witt Kristine L.,
Bishop Jack B.
Publication year - 2007
Publication title -
environmental and molecular mutagenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 87
eISSN - 1098-2280
pISSN - 0893-6692
DOI - 10.1002/em.20191
Subject(s) - zidovudine , mitochondrial toxicity , lamivudine , mitochondrial dna , biology , virology , toxicity , reverse transcriptase , in utero , dna damage , gestation , physiology , pharmacology , pregnancy , virus , medicine , fetus , dna , viral disease , human immunodeficiency virus (hiv) , genetics , rna , gene , hepatitis b virus
Antiretroviral therapies based on nucleoside reverse transcriptase inhibitors (NRTIs), like zidovudine (3′‐azido‐3′‐deoxythymidine; AZT) and lamivudine ((‐)2′,3′‐dideoxy‐3′‐thiacytidine; 3TC), markedly reduce mother‐to‐child transmission of the human immunodeficiency virus (HIV). However, AZT induces damage in nuclear DNA of mice exposed in utero and postnatally, and mitochondrial DNA (mtDNA) damage has been observed in both human and mouse neonates following perinatal exposure to AZT and AZT/3TC in combination. To provide animal data modeling the NRTI‐induced heart damage reported in human infants, we treated pregnant CD‐1 mice throughout gestation and treated their pups by direct gavage from postnatal day (PND) 4 through PND 28 with daily doses of 150 mg/kg body weight (bw)/day AZT, 75 mg/kg bw/day 3TC, 125/62.5 mg/kg bw/day AZT/3TC, or the vehicle control. Half the pups were euthanized on PND 28; the remainder received no further dosing, and were euthanized at week 10. Heart tissue was collected, total DNA was extracted, and mtDNA copy number relative to nuclear DNA copy number, mtDNA damage, and mtDNA mutation assays were performed using PCR‐based methods. Analyses revealed increases in mtDNA lesions in 4‐week‐old males and females treated with AZT or 3TC, but not in 10‐week‐old mice, suggesting that the damage resolved after treatment ceased. Interestingly, 10‐week‐old females treated with AZT/3TC had significant increases in mtDNA damage. Point mutations were elevated in 10‐week‐old females treated with AZT or AZT/3TC, but not 3TC; no increases in mutations were seen in either gender at 4 weeks of age. Our data suggest that AZT/3TC combination treatment produces greater mtDNA damage than either agent individually, and that female mice are more sensitive than males to AZT/3TC‐induced mtDNA damage. Environ. Mol. Mutagen., 2006. Published 2006 Wiley‐Liss, Inc.